News Â鶹´«Ã½ from Wistar Institute display Latest news from Wistar Institute on News en-us Copyright 2024 News News Â鶹´«Ã½ from Wistar Institute 115 31 / /images/newswise-logo-rss.gif Wistar Institute and Cameroon Researchers Reveals HIV Latency Reversing Properties in African Plant /articles/wistar-institute-and-cameroon-researchers-reveals-hiv-latency-reversing-properties-in-african-plant/?sc=rsin /articles/wistar-institute-and-cameroon-researchers-reveals-hiv-latency-reversing-properties-in-african-plant/?sc=rsin Tue, 19 Nov 2024 13:55:23 EST A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of African tree that has been used in traditional healing in Cameroon to treat a variety of diseases and conditions including cancers and diabetes. Wistar Institute The Wistar Institute's Education and Training Center Receives $100,000 NIIMBL eXperience Grant /articles/the-wistar-institute-s-education-and-training-center-receives-100-000-niimbl-experience-grant/?sc=rsin /articles/the-wistar-institute-s-education-and-training-center-receives-100-000-niimbl-experience-grant/?sc=rsin Thu, 14 Nov 2024 14:40:04 EST The Wistar Institute's Hubert J.P. Schoemaker Education and Training Center was the recipient of a $100,000 eXperience grant from NIIMBL to support an immersive weeklong training program at the Institute. Wistar Institute Scientists at The Wistar Institute Discover Novel Series of SARS-CoV-2 Mpro Inhibitors for Potential New COVID-19 Treatments /articles/scientists-at-the-wistar-institute-discover-novel-series-of-sars-cov-2-mpro-inhibitors-for-potential-new-covid-19-treatments/?sc=rsin /articles/scientists-at-the-wistar-institute-discover-novel-series-of-sars-cov-2-mpro-inhibitors-for-potential-new-covid-19-treatments/?sc=rsin Tue, 08 Oct 2024 09:05:52 EST New research from the Salvino lab identifies novel series of MPro inhibitors Wistar Institute Wistar Institute Researchers Identify Parkinson-related Protein's Role in Cancer and T Cell Activation /articles/wistar-institute-researchers-identify-parkinson-related-protein-s-role-in-cancer-and-t-cell-activation/?sc=rsin /articles/wistar-institute-researchers-identify-parkinson-related-protein-s-role-in-cancer-and-t-cell-activation/?sc=rsin Tue, 17 Sep 2024 14:05:48 EST Wistar scientists have demonstrated the role of Parkin -- a protein implicated in Parkinson's disease -- in the body's innate immune response to cancer. Wistar Institute Scientists at The Wistar Institute Clone Several New Anti-Interferon Antibodies - Developing Future Therapeutic Candidates with Broad Application Potential /articles/scientists-at-the-wistar-institute-clone-several-new-anti-interferon-antibodies-developing-future-therapeutic-candidates-with-broad-application-potential/?sc=rsin /articles/scientists-at-the-wistar-institute-clone-several-new-anti-interferon-antibodies-developing-future-therapeutic-candidates-with-broad-application-potential/?sc=rsin Tue, 17 Sep 2024 14:05:21 EST Wistar Institute scientists have successfully isolated and cloned fully human antibodies that can block specific Type-I interferon molecules in vitro; their discovery has an array of potential clinical & research applications, enabling scientists with a new way to investigate the role of specific Type-I interferons in a variety of diseases. Wistar Institute The Wistar Institute Grows Research Enterprise Signs New Lease at uCity Square /articles/the-wistar-institute-grows-research-enterprise-signs-new-lease-at-ucity-square/?sc=rsin /articles/the-wistar-institute-grows-research-enterprise-signs-new-lease-at-ucity-square/?sc=rsin Tue, 13 Aug 2024 10:00:00 EST The Wistar Institute and Wexford Science & Technology, LLC, announced that Wistar has signed a lease for new laboratory and office space at uCity Square in Philadelphia to expand its capacity and resources essential for making groundbreaking discoveries that advance human health. Wistar Institute Wistar Celebrates Accomplishments of Diverse, Next-Gen Students & Pre-apprentices Completing Summer Science Education & Training Programs /articles/wistar-celebrates-accomplishments-of-diverse-next-gen-students-pre-apprentices-completing-summer-science-education-training-programs/?sc=rsin /articles/wistar-celebrates-accomplishments-of-diverse-next-gen-students-pre-apprentices-completing-summer-science-education-training-programs/?sc=rsin Thu, 01 Aug 2024 10:05:11 EST Wistar Celebrates Accomplishments of 58 Diverse, Next-Gen Students & Pre-apprentices Completing Summer Science Education & Training Programs. Wistar Institute Wistar to Honor 2023 Nobel Prize Winner Dr. Katalin Kariko /articles/wistar-to-honor-2023-nobel-prize-winner-dr-katalin-karik/?sc=rsin /articles/wistar-to-honor-2023-nobel-prize-winner-dr-katalin-karik/?sc=rsin Thu, 25 Jul 2024 11:05:02 EST Wistar Institute honors 2023 Nobel laureate Katalin Kariko, Ph.D., as the 2024 Helen Dean King Award recipient on October 8, 2024 at noon (ET). Wistar Institute Nobel Laureate Drew Weissman, M.D., Ph.D., Delivers 28th Annual Jonathan Lax Memorial Lecture at The Wistar Institute /articles/nobel-laureate-drew-weissman-m-d-ph-d-delivers-28th-annual-jonathan-lax-memorial-lecture-at-the-wistar-institute/?sc=rsin /articles/nobel-laureate-drew-weissman-m-d-ph-d-delivers-28th-annual-jonathan-lax-memorial-lecture-at-the-wistar-institute/?sc=rsin Wed, 10 Jul 2024 14:05:35 EST July 16th at 6:30 pm EDT, Nobel Laureate in Medicine or Physiology Drew Weissman, M.D., Ph.D., delivers the 28th annual Jonathan Lax Memorial Lecture at The Wistar Institute in recognition of his outstanding contributions to HIV research. Wistar Institute Revolutionizing Cancer Treatment: Wistar and Accelerated Biosciences Collaborate to Pioneer Transformative Immune Cell Therapies /articles/revolutionizing-cancer-treatment-wistar-and-accelerated-biosciences-collaborate-to-pioneer-transformative-immune-cell-therapies/?sc=rsin /articles/revolutionizing-cancer-treatment-wistar-and-accelerated-biosciences-collaborate-to-pioneer-transformative-immune-cell-therapies/?sc=rsin Wed, 10 Jul 2024 10:40:58 EST The Wistar Institute is pleased to announce a research collaboration with Accelerated Biosciences Corp. aimed at creating a platform based on human trophoblast stem cells to explore new immunotherapies that use Accelerated Bio's proprietary technology. Wistar Institute Wistar Recruits Jozef Madzo, Ph.D., as Director of Bioinformatics /articles/wistar-recruits-jozef-madzo-ph-d-as-director-of-bioinformatics/?sc=rsin /articles/wistar-recruits-jozef-madzo-ph-d-as-director-of-bioinformatics/?sc=rsin Mon, 01 Jul 2024 14:05:09 EST Jozef Madzo, Ph.D., recruited as an assistant professor and director of Bioinformatics, at The Wistar Institute. Wistar Institute Wistar's Dr. Noam Auslander Awarded $600K V Foundation Grant to Identify Connections between Gut Microbial Genes & Melanoma immunotherapy /articles/wistar-s-dr-noam-auslander-awarded-600k-v-foundation-grant-to-identify-connections-between-gut-microbial-genes-melanoma-immunotherapy/?sc=rsin /articles/wistar-s-dr-noam-auslander-awarded-600k-v-foundation-grant-to-identify-connections-between-gut-microbial-genes-melanoma-immunotherapy/?sc=rsin Thu, 27 Jun 2024 10:35:51 EST The Wistar Institute's Dr. Noam Auslander was awarded a $600,000 Women Scientists Innovation Award for Cancer Research grant from the V Foundation for Cancer Research to support the next three years of her research, which will use proteins of gut bacteria to predict immunotherapy benefit in melanoma. Wistar Institute Wistar Scientists Develop Novel Antibody Treatment for Kidney Cancer /articles/wistar-scientists-develop-novel-antibody-treatment-for-kidney-cancer/?sc=rsin /articles/wistar-scientists-develop-novel-antibody-treatment-for-kidney-cancer/?sc=rsin Tue, 04 Jun 2024 11:05:06 EST Wistar scientists have built upon BTE technology to develop new and improved recombinant and synthetic DNA versions of therapeutic antibodies that target CA9, called Persistent Multivalent T Cell Engager (CA9-PMTE), that shows promise in pre-clinical models as a potent, long-lasting treatment against ccRCC. Wistar Institute Wistar Research Identifies Mechanisms for Selective Multiple Sclerosis Treatment Strategy /articles/wistar-research-identifies-mechanisms-for-selective-multiple-sclerosis-treatment-strategy/?sc=rsin /articles/wistar-research-identifies-mechanisms-for-selective-multiple-sclerosis-treatment-strategy/?sc=rsin Tue, 28 May 2024 13:05:30 EST Wistar Institute's Paul M. Lieberman, Ph.D., and lab, have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contribute to a pathogenic, inflammatory phenotype that contributes to multiple sclerosis (MS); the group has also shown how these problematic B cells can be selectively targeted in a way that reduces the damaging autoimmune response of multiple sclerosis. Wistar Institute The Wistar Institute Awarded Second National Science Foundation Grant to Expand Award-winning STEM Training Program /articles/the-wistar-institute-awarded-second-national-science-foundation-grant-to-expand-award-winning-stem-training-program/?sc=rsin /articles/the-wistar-institute-awarded-second-national-science-foundation-grant-to-expand-award-winning-stem-training-program/?sc=rsin Tue, 14 May 2024 13:05:16 EST Wistar was awarded a $649,971 grant from the National Science Foundation (NSF) to support the continued expansion of its award-winning Biomedical Technician Training (BTT) Pre-apprenticeship Program. Wistar Institute Wistar Scientists Discover New Immunosuppressive Mechanism in Brain Cancer /articles/wistar-scientists-discover-new-immunosuppressive-mechanism-in-brain-cancer/?sc=rsin /articles/wistar-scientists-discover-new-immunosuppressive-mechanism-in-brain-cancer/?sc=rsin Fri, 03 May 2024 11:00:00 EST The Wistar Institute assistant professor Dr. Filippo Veglia has discovered a key mechanism of how glioblastoma -- a serious and often fatal brain cancer -- suppresses the immune system so that the tumor can grow unimpeded by the body's defenses. Wistar Institute Promising Personalized Approach to Liver Cancer Therapy Made Possible by DNA-based Neoantigen Research Designed at The Wistar Institute /articles/promising-personalized-approach-to-liver-cancer-therapy-made-possible-by-dna-based-neoantigen-research-designed-at-the-wistar-institute/?sc=rsin /articles/promising-personalized-approach-to-liver-cancer-therapy-made-possible-by-dna-based-neoantigen-research-designed-at-the-wistar-institute/?sc=rsin Wed, 01 May 2024 09:10:33 EST Results of a new clinical trial published in Nature Medicine show that a novel, personalized neoantigen vaccine therapy demonstrated promising anti-tumor efficacy in patients with liver cancer who failed their original front-line treatment. The foundational biomedical research leading to this important study and important outcome originated from research in the Vaccine & Immunotherapy Center at The Wistar Institute. Wistar Institute Wistar Scientists Identify Pro-aging 'Sugar Signature' in the Blood of People Living with HIV /articles/wistar-scientists-identify-pro-aging-sugar-signature-in-the-blood-of-people-living-with-hiv/?sc=rsin /articles/wistar-scientists-identify-pro-aging-sugar-signature-in-the-blood-of-people-living-with-hiv/?sc=rsin Wed, 10 Apr 2024 09:30:19 EST Wistar's Dr. Abdel-Mohsen has identified sugar abnormalities in the blood that may promote biological aging and inflammation in people living with HIV. Wistar Institute The Wistar Institute Appoints Max Berger to its Board of Trustees /articles/the-wistar-institute-appoints-max-berger-to-its-board-of-trustees/?sc=rsin /articles/the-wistar-institute-appoints-max-berger-to-its-board-of-trustees/?sc=rsin Tue, 27 Feb 2024 11:05:28 EST The Wistar Institute Appoints Max Berger to its Board of Trustees Wistar Institute Wistar Scientists Discover Link Between Leaky Gut and Accelerated Biological Aging /articles/wistar-scientists-discover-link-between-leaky-gut-and-accelerated-biological-aging/?sc=rsin /articles/wistar-scientists-discover-link-between-leaky-gut-and-accelerated-biological-aging/?sc=rsin Fri, 23 Feb 2024 10:05:19 EST Wistar Institute's Dr. Mohamed Abdel-Mohsen has demonstrated a connection between viral damage to the gut and premature biological aging. Wistar Institute